Cargando…
Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report
BACKGROUND: Neoplastic pericardial effusion (NPE) is a rare consequence of rectal cancer and carries a poor prognosis. Optimal management has yet to be determined. Fruquintinib is an oral anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor approved by the China Food and Drug A...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316928/ https://www.ncbi.nlm.nih.gov/pubmed/34368339 http://dx.doi.org/10.12998/wjcc.v9.i21.6170 |